Prostate Cancer - Results from #20160

Low grade prostate cancer diverges early from high grade and metastatic disease - Abstract July 16, 2014

Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors - Abstract July 16, 2014

Abiraterone acetate and castration resistant ductal adenocarcinoma of the prostate - Abstract July 16, 2014

Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases - Abstract July 16, 2014

Performance of the genomic evaluators of metastatic prostate cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients - Abstract July 16, 2014

Is there an anti-androgen withdrawal syndrome with enzalutamide? - Abstract July 16, 2014

Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy - Abstract July 15, 2014

The importance of dietary change for men diagnosed with and at risk of prostate cancer: A multi-centre interview study with men, their partners and health professionals - Abstract July 15, 2014

Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: Study protocol for a pilot randomised controlled trial - Abstract July 15, 2014

Changes in sexual roles and quality of life for gay men after prostate cancer: Challenges for sexual health providers - Abstract July 15, 2014

MR imaging of the prostate - Abstract July 15, 2014

Preoperative lymph node staging in patients with primary prostate cancer: Comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT - Abstract July 15, 2014

The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions - Abstract July 14, 2014

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: - Abstract July 14, 2014

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer - Abstract July 14, 2014

Prostate cancer survivorship: A review of erectile dysfunction and penile rehabilitation after prostate cancer therapy - Abstract July 12, 2014

More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer - Abstract July 12, 2014

Novel tools for prostate cancer prognosis, diagnosis, and follow-up - Abstract July 12, 2014

Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer - Abstract July 11, 2014

Geographic variation in prostate cancer survival in New South Wales - Abstract July 11, 2014

Page 1009 of 1436